Overall, it seems that both pharmacological manipulations led to a reduction in discounting, with the strongest effects for the amisulpride challenge and a nonsignificant trend for the naltrexone challenge.
← all excerpts
Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans.
1
—
—